Enabling Technologies for Modern Drug Delivery

The increasing number of challenging new chemical entities in development coupled with the pressure to reduce R&D and production costs have created the perfect storm in the pharmaceutical industry. Using a science-based approach to excipient selection will allow you to overcome challenges such as poor bioavailability and stability while optimizing the formulation using the manufacturing process that is most effective and efficient. Thomas Dürig, PhD Dr. Tom Dürig is a Senior R&D Director leads global research and development and technical services for Pharmaceutical and Nutrition Specialities. These groups, located in North America, Europe, Middle East, Latin America, and Asia provide technical service and are focused on research and development of highly functional materials that enable overcoming drug delivery challenges such as bioavailability enhancement, drug stabilization and controlled drug delivery as well as process technologies to achieve advanced drug delivery and continuous manufacturing. Tom is a registered pharmacist, with over 20 years’ experience in the industry. He received the Degree of Doctor of Philosophy in Pharmaceutical Sciences from Temple University, Philadelphia. He has worked in a variety of settings, including R&D, GMP manufacturing at major multi-national corporations and in academia. Dr. Dürig holds several patents pertaining to polymeric excipients and advanced dosage form design and efficacy usability allure integrity profitabilityTM Ashland Ashland Pharmaceutical Technology Symposium on Enabling Technologies for Modern Drug Delivery September 14th, 2017 Embassy Suites by Hilton San Francisco Airport Waterfront 150 Anza Blvd, Burlingame, CA 94010 Presentation Abstract and Speaker Bios: Reducing Formulation Risk with Science-based Excipient Selection Abstract: The increasing number of challenging new chemical entities in development coupled with the pressure to reduce R&D and production costs have created the perfect storm in the pharmaceutical industry. Using a science-based approach to excipient selection will allow you to ov rcome challenges such as p or bi availability and stability while optimizing the formulation using the manufa turing process that is most ffective and efficient. The increasing number of challenging new chemical entities in development coupled with the pressure to reduce R&D and production costs have created the perfect storm in the pharmaceutical industry. Using a science-based approach to excipient selection will allow you to ov rcome challenges such as p or bi availability and stability while optimizing the formulation using the manufa turing process that is most ffective and efficient.